MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Scoring Algorithm-Based Genomic Testing in Dystonia: real-life data from the outpatient clinic

E. Indelicato, M. Amprosi, A. Eigentler, W. Nachbauer, R. Granata, M. Zech, S. Boesch (Innsbruck, Austria)

Meeting: 2022 International Congress

Abstract Number: 560

Keywords: Dystonia: Genetics

Category: Dystonia: Epidemiology, Genetics, Phenomenology

Objective: To test a scoring algorithm to guide genetic testing in dystonia.

Background: Recent evidence from a large multicentric study allowed to establish a scoring algorithm aiding the choice of a whole exome sequencing study (WES) in patients with dystonia (Zech et al). Defined positive predictors consist of an age at onset <20 (2 points), segmental/generalized involvement (1 point) as well as the presence of further neurological symptoms (1 to 2 points). This scoring algorithm has been validated in a multicentric cohort of prospectively recruited patients. Real life data from dystonia outpatient clinics are missing.

Method: We screened the patients regularly attending the dystonia outpatient clinic of the Innsbruck medical university excluding acquired forms (e.g. history of trauma, neuroleptic intakes etc.) as well as cases of secondary dystonia (e.g. oromandibular dystonia or blepharospasms within clinically clear atypical parkinsonism). WES studies were performed within a cooperation study with the technical University of Munich.

Results: In our dystonia outpatient clinic 368 patients with primary dystonia are regularly followed. WES was performed in 4/4 patients with score 5, 27/27 patients with score 3-4 and 138/336 patients with score £2 (total 169). WES yielded a genetic diagnosis in 3 out of 4 patients with a score of 5 (75%), in 16 out of 27 patients with a score 3-4 (59%) and in 9 out of 138 patients with a score £2 (6,5%).

Conclusion: As expected, the diagnostic yield of WES in our dystonia cohort correlates with a higher predictive score. However, our positivity rates were overall higher than previously described in an unselected prospective population (51%, 25% and 2% with a score of 5, 3 to 4 and £2 respectively). Our real-life data outline the even greater diagnostic rate of WES in the setting of a clinically well-defined dystonia population.

References: M Zech, R Jech, S Boesch, et al. Monogenic variants in dystonia: an exome-wide sequencing study. Lancet Neurol, 19 (2020), pp. 908-918

To cite this abstract in AMA style:

E. Indelicato, M. Amprosi, A. Eigentler, W. Nachbauer, R. Granata, M. Zech, S. Boesch. Scoring Algorithm-Based Genomic Testing in Dystonia: real-life data from the outpatient clinic [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/scoring-algorithm-based-genomic-testing-in-dystonia-real-life-data-from-the-outpatient-clinic/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/scoring-algorithm-based-genomic-testing-in-dystonia-real-life-data-from-the-outpatient-clinic/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley